Cargando…

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers

Germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene were recently identified in individuals with pituitary adenoma predisposition (PAP). These patients have prolactin (PRL) or growth hormone (GH) oversecreting pituitary adenomas, the latter exhibiting acromegaly or gig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georgitsi, M, Karhu, A, Winqvist, R, Visakorpi, T, Waltering, K, Vahteristo, P, Launonen, V, Aaltonen, L A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360003/ https://www.ncbi.nlm.nih.gov/pubmed/17242703 http://dx.doi.org/10.1038/sj.bjc.6603573

Ejemplares similares

Somatic mutation analysis of MYH11 in breast and prostate cancer
por: Alhopuro, Pia, et al.
Publicado: (2008)

Mutation analysis of three genes encoding novel LKB1-interacting proteins, BRG1, STRADα, and MO25α, in Peutz–Jeghers syndrome
por: Alhopuro, P, et al.
Publicado: (2005)

Circulating aryl hydrocarbon receptor-interacting protein (AIP) is independent of GH secretion
por: Stojanovic, Marko, et al.
Publicado: (2019)

Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families
por: Igreja, Susana, et al.
Publicado: (2010)

The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene
por: Vroonen, Laurent, et al.
Publicado: (2023)

MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
por: Kämpjärvi, Kati, et al.
Publicado: (2016)

Identification of 33 candidate oncogenes by screening for base-specific mutations
por: Tuupanen, S, et al.
Publicado: (2014)

Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
por: Dénes, Judit, et al.
Publicado: (2015)

An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene
por: Dinesen, Pia T, et al.
Publicado: (2015)

Global metabolomic profiling of uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line
por: Fukuda, Takashi, et al.
Publicado: (2016)

High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer
por: Pärssinen, J, et al.
Publicado: (2007)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

An inherited NBN mutation is associated with poor prognosis prostate cancer
por: Cybulski, C, et al.
Publicado: (2013)

Rapid progression of prostate cancer in men with a BRCA2 mutation
por: Narod, S A, et al.
Publicado: (2008)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

iAIPs: Identifying Anti-Inflammatory Peptides Using Random Forest
por: Zhao, Dongxu, et al.
Publicado: (2021)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
por: Seppälä, T T, et al.
Publicado: (2015)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
por: Akbari, M R, et al.
Publicado: (2014)

Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome
por: Vickaryous, N, et al.
Publicado: (2008)

Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation
por: Pinheiro, Manuela, et al.
Publicado: (2015)

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
por: Phipps, A I, et al.
Publicado: (2013)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families
por: Ray, A M, et al.
Publicado: (2009)

Gene expression signatures for colorectal cancer microsatellite status and HNPCC
por: Kruhøffer, M, et al.
Publicado: (2005)

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
por: Maier, C, et al.
Publicado: (2005)

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer
por: Tomlinson, I P M, et al.
Publicado: (2010)

Isolated Macroprolactinomas in Four Young Adult Males Harboring a Variant of the Aryl Hydrocarbon Interacting Protein (AIP) Gene: Isn’t It Too Much of a Coincidence?
por: Chaves, Carolina Marques, et al.
Publicado: (2021)

PreAIP: Computational Prediction of Anti-inflammatory Peptides by Integrating Multiple Complementary Features
por: Khatun, Mst. Shamima, et al.
Publicado: (2019)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases
por: Karoui, M, et al.
Publicado: (2004)

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
por: Leongamornlert, D, et al.
Publicado: (2014)

A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants
por: Theodoratou, E, et al.
Publicado: (2010)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
por: Phelan, C M, et al.
Publicado: (2014)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019)

MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease
por: Pinto, C, et al.
Publicado: (2006)

Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach
por: Gille, J J P, et al.
Publicado: (2002)

Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
por: Mühlbauer, K-R, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_jphnnqoteu2ns3v3mfrp0ukp7i